SCoV-2 Detect™ IgG ELISA
FDA Emergency Use Authorized
SCoV-2 DetectTM IgG ELISA kit is an in vitro diagnostic test for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum.
The test is intended as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. At this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity. The SCoV-2 Detect™ IgG ELISA should not be used to diagnose acute SARS‑CoV‑2 infection.
Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform high complexity tests.
Please click here for Frequently Asked Questions.
Click Downloads Below For:
- Letter of Authorization
- Package Insert
- Package Insert (Spanish)
- Recipient Fact Sheet
- Health Care Provider Fact Sheet
- IgG ELISA Brochure
- SDS (US)